RHEB (Ras homolog enriched in brain) is a small GTPase protein that functions as a critical molecular switch in cellular nutrient sensing and growth regulation. Encoded by the RHEB gene, this protein belongs to the Ras superfamily of GTPases and is particularly abundant in neuronal tissues, where it plays a central role in controlling the mechanistic target of rapamycin complex 1 (mTORC1). RHEB cycles between an active GTP-bound state and an inactive GDP-bound state, allowing it to serve as a molecular gatekeeper that translates nutrient availability—particularly amino acids—into cellular growth signals. Dysregulation of RHEB activity has emerged as a significant factor in multiple neurodegenerative diseases, making it an important target for understanding neuronal cell death and dysfunction.
Function/Biology
RHEB operates primarily as an activator of mTORC1, a master regulatory complex composed of the mTOR kinase, Raptor, mLST8, and PRAS40. When amino acids are abundant, RHEB adopts its GTP-bound active conformation and directly interacts with mTORC1, catalyzing its phosphorylation and activation. This activation subsequently promotes protein synthesis through phosphorylation of ribosomal protein S6 kinase (S6K) and eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1), while simultaneously suppressing catabolic processes including autophagy and lysosomal degradation through inhibition of the ULK1 complex.
...
RHEB Protein
Overview
RHEB (Ras homolog enriched in brain) is a small GTPase protein that functions as a critical molecular switch in cellular nutrient sensing and growth regulation. Encoded by the RHEB gene, this protein belongs to the Ras superfamily of GTPases and is particularly abundant in neuronal tissues, where it plays a central role in controlling the mechanistic target of rapamycin complex 1 (mTORC1). RHEB cycles between an active GTP-bound state and an inactive GDP-bound state, allowing it to serve as a molecular gatekeeper that translates nutrient availability—particularly amino acids—into cellular growth signals. Dysregulation of RHEB activity has emerged as a significant factor in multiple neurodegenerative diseases, making it an important target for understanding neuronal cell death and dysfunction.
Function/Biology
RHEB operates primarily as an activator of mTORC1, a master regulatory complex composed of the mTOR kinase, Raptor, mLST8, and PRAS40. When amino acids are abundant, RHEB adopts its GTP-bound active conformation and directly interacts with mTORC1, catalyzing its phosphorylation and activation. This activation subsequently promotes protein synthesis through phosphorylation of ribosomal protein S6 kinase (S6K) and eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1), while simultaneously suppressing catabolic processes including autophagy and lysosomal degradation through inhibition of the ULK1 complex.
The cycling of RHEB between GTP and GDP states is tightly controlled by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). GATOR1 complex components act as GAPs to promote RHEB's conversion to the inactive GDP state, thereby providing negative regulation of mTORC1 signaling. This interplay allows cells to quickly respond to changes in nutrient status and energy availability.
Role in Neurodegeneration
RHEB dysfunction contributes to neurodegeneration through multiple interconnected mechanisms. Excessive mTORC1 activation driven by RHEB dysregulation leads to accumulation of protein aggregates—including tau and α-synuclein—because sustained protein synthesis without adequate autophagy creates an imbalance favoring aggregate formation. Conversely, impaired RHEB activity and resulting mTORC1 insufficiency can fail to support the high metabolic demands of neurons, causing selective neuronal vulnerability and death.
In Alzheimer's disease, dysregulated RHEB-mTORC1 signaling impairs the clearance of amyloid-beta and phosphorylated tau, contributing to neuritic dysfunction and synaptic loss. In Parkinson's disease, abnormal RHEB regulation compromises the selective autophagy of damaged mitochondria (mitophagy) and the clearance of α-synuclein inclusions. Tuberous sclerosis complex (TSC), a genetic disorder caused by mutations in TSC1 or TSC2 genes encoding GATOR1 complex components, results in uncontrolled RHEB-mTORC1 signaling and neurological complications including seizures and cognitive decline due to aberrant neuronal growth and proliferation.
Molecular Mechanisms
RHEB's interaction with mTORC1 involves specific amino acid sequences within RHEB's switch regions that recognize and bind to Raptor, facilitating mTORC1 kinase activation. The GATOR1 complex (comprising DEPDC5, NPRL2, and NPRL3) regulates RHEB by catalyzing GTP hydrolysis through GAP activity. Conversely, GATOR2 and KICSTOR complexes inhibit GATOR1, allowing RHEB accumulation in its active GTP-bound state during amino acid sufficiency.
Calcium/calmodulin-dependent protein kinase kinase beta (CaMKKβ) and AMP-activated protein kinase (AMPK) also regulate RHEB signaling through metabolic stress sensing, phosphorylating TSC2 and thereby enhancing GATOR1 activity during energy depletion.
Clinical/Research Significance
RHEB represents a promising therapeutic target for neurodegenerative diseases. Modulating RHEB-mTORC1 signaling through agents like rapamycin (an mTORC1 inhibitor) has shown neuroprotective effects in preclinical models of multiple neurodegenerative conditions. Understanding RHEB dysfunction provides insights into disease mechanisms and informs development of precision treatments targeting nutrient sensing and cellular quality control pathways in neurons.